000277314 001__ 277314
000277314 005__ 20240229155013.0
000277314 0247_ $$2doi$$a10.1111/cts.13547
000277314 0247_ $$2pmid$$apmid:37391924
000277314 0247_ $$2ISSN$$a1752-8054
000277314 0247_ $$2ISSN$$a1752-8062
000277314 0247_ $$2altmetric$$aaltmetric:151015131
000277314 037__ $$aDKFZ-2023-01332
000277314 041__ $$aEnglish
000277314 082__ $$a610
000277314 1001_ $$00000-0003-0928-4049$$aDhaenens, Britt A E$$b0
000277314 245__ $$aOptimizing expert and patient input in pediatric trial design: Lessons learned and recommendations from a collaboration between conect4children and European Patient-CEntric ClinicAl TRial PLatforms.
000277314 260__ $$aOxford$$bBlackwell [[-2008]]$$c2023
000277314 3367_ $$2DRIVER$$aarticle
000277314 3367_ $$2DataCite$$aOutput Types/Journal article
000277314 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1692970840_16395
000277314 3367_ $$2BibTeX$$aARTICLE
000277314 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000277314 3367_ $$00$$2EndNote$$aJournal Article
000277314 500__ $$a2023 Aug;16(8):1458-1468
000277314 520__ $$aAdvice from multiple stakeholders is required to design the optimal pediatric clinical trial. We present recommendations for acquiring advice from trial experts and patients/caregivers, derived from advice meetings that were performed through a collaboration of the Collaborative Network for European Clinical Trials for Children (c4c) and the European Patient-CEntric ClinicAl TRial PLatforms (EU-PEARL). Three advice meetings were performed: (1) an advice meeting for clinical and methodology experts, (2) an advice meeting for patients/caregivers, and (3) a combined meeting with both experts and patients/caregivers. Trial experts were recruited from c4c database. Patients/caregivers were recruited through a patient organization. Participants were asked to provide input on a trial protocol, including endpoints, outcomes, and the assessment schedule. Ten experts, 10 patients, and 13 caregivers participated. The advice meetings resulted in modification of eligibility criteria and outcome measures. We have provided recommendations for the most effective meeting type per protocol topic. Topics with limited options for patient input were most efficiently discussed in expert advice meetings. Other topics benefit from patient/caregiver input, either through a combined meeting with experts or a patients/caregivers-only advice meeting. Some topics, such as endpoints and outcome measures, are suitable for all meeting types. Combined sessions profit from synergy between experts and patients/caregivers, balancing input on protocol scientific feasibility and acceptability. Both experts and patients/caregivers provided critical input on the presented protocol. The combined meeting was the most effective methodology for most protocol topics. The presented methodology can be used effectively to acquire expert and patient feedback.
000277314 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000277314 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000277314 7001_ $$00000-0001-6851-5455$$aMahler, Fenna$$b1
000277314 7001_ $$00000-0002-8729-9951$$aBatchelor, Hannah$$b2
000277314 7001_ $$aDicks, Pamela$$b3
000277314 7001_ $$aGaillard, Segolene$$b4
000277314 7001_ $$00000-0002-4494-3663$$aNafria, Begonya$$b5
000277314 7001_ $$0P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aKopp-Schneider, Annette$$b6$$udkfz
000277314 7001_ $$aRibeiro, Maria Alexandra$$b7
000277314 7001_ $$aSchwab, Matthias$$b8
000277314 7001_ $$aSparber-Sauer, Monika$$b9
000277314 7001_ $$aLeubner, Jonas$$b10
000277314 7001_ $$00000-0002-0502-0647$$ade Wildt, Saskia N$$b11
000277314 7001_ $$00000-0001-7919-8934$$aOostenbrink, Rianne$$b12
000277314 773__ $$0PERI:(DE-600)2433157-0$$a10.1111/cts.13547$$gp. cts.13547$$n8$$p1458-1468$$tClinical and translational science$$v16$$x1752-8054$$y2023
000277314 909CO $$ooai:inrepo02.dkfz.de:277314$$pVDB
000277314 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000277314 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000277314 9141_ $$y2023
000277314 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-04-16T15:13:15Z
000277314 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-04-16T15:13:15Z
000277314 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2021-04-16T15:13:15Z
000277314 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-23
000277314 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-23
000277314 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-23
000277314 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-23
000277314 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-23
000277314 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCTS-CLIN TRANSL SCI : 2022$$d2023-10-25
000277314 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
000277314 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
000277314 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-25
000277314 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-25
000277314 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-25
000277314 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
000277314 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-25
000277314 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
000277314 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-25
000277314 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000277314 980__ $$ajournal
000277314 980__ $$aVDB
000277314 980__ $$aI:(DE-He78)C060-20160331
000277314 980__ $$aUNRESTRICTED